Publications by authors named "Johan Verhelst"

Claim this Profile
T
The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysis.
Johan Verhelst, Anders F Mattsson, Cecilia Camacho-Hübner, Anton Luger, Roger Abs

Endocr Connect· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement.
Kevin C J Yuen, Anders F Mattsson, Pia Burman, Eva-Marie Erfurth, Cecilia Camacho-Hubner, Johan Verhelst

J Clin Endocrinol Metab· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis.
Roger Abs, Anders F Mattsson, Maria Thunander, Johan Verhelst, Miklós I Góth

Eur J Endocrinol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active acromegaly is associated with decreased hs-CRP and NT-proBNP serum levels: insights from the Belgian registry of acromegaly.
Johan Verhelst, Brigitte Velkeniers, Dominique Maiter, Patrick Haentjens, Guy T'Sjoen

Eur J Endocrinol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational study.
Anton Luger, Anders F Mattsson, Maria Koltowska-Häggström, Maria Thunander, Miklos Góth, Johan Verhelst

Diabetes Care· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis.
Johan Verhelst, Anders F Mattsson, Anton Luger, Maria Thunander, Miklós I Góth

Eur J Endocrinol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flexion contractures in secondary adrenal insufficiency.
Jan Berger, Piet Herregods, Johan Verhelst, Gaëtane Stassijns, Rudi Chappel

Clin Rheumatol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular risk factors in hypopituitary GH-deficient adults.
Johan Verhelst, Roger Abs

Eur J Endocrinol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modification of hormonal secretion in clinically silent pituitary adenomas.
Tania Daems, Johan Verhelst, Alex Michotte, Pascale Abrams, Dirk De Ridder

Pituitary· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission of acromegaly following long-term therapy with cabergoline: report of two cases.
Johan A Verhelst, Pascale J Abrams, Roger Abs

Pituitary· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients.
Etienne Delgrange, Tania Daems, Johan Verhelst, Roger Abs, Dominique Maiter

Eur J Endocrinol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimalization and cost management of lanreotide-Autogel therapy in acromegaly.
Pascale Abrams, Orsalia Alexopoulou, Roger Abs, Dominique Maiter, Johan Verhelst

Eur J Endocrinol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiomyopathy and thyrotoxicosis: tachycardiomyopathy or thyrotoxic cardiomyopathy?
Tom Vydt, Johan Verhelst, Gilles De Keulenaer

Acta Cardiol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
Roger Abs, Anders F Mattsson, Bengt-Ake Bengtsson, Ulla Feldt-Rasmussen, Miklós I Góth, Johan Verhelst

Growth Horm IGF Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).
Johan Verhelst, Pat Kendall-Taylor, Eva Marie Erfurth, David Anthony Price, Mitchell Geffner

J Clin Endocrinol Metab· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperprolactinemia: pathophysiology and management.
Johan Verhelst, Roger Abs

Treat Endocrinol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma.
Pat Kendall-Taylor, Peter J Jönsson, Roger Abs, Eva Marie Erfurth, Maria Koltowska-Häggström, Johan Verhelst

Eur J Endocrinol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database).
Mitchell Geffner, Michael Lundberg, Maria Koltowska-Häggström, Roger Abs, Johan Verhelst

J Clin Endocrinol Metab· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term growth hormone replacement therapy in hypopituitary adults.
Johan Verhelst, Roger Abs

Drugs· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis